328 related articles for article (PubMed ID: 27782043)
1. Photodynamic Therapy for Non-Melanoma Skin Cancers.
Cohen DK; Lee PK
Cancers (Basel); 2016 Oct; 8(10):. PubMed ID: 27782043
[TBL] [Abstract][Full Text] [Related]
2. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer.
Marmur ES; Schmults CD; Goldberg DJ
Dermatol Surg; 2004 Feb; 30(2 Pt 2):264-71. PubMed ID: 14871220
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic Therapy and Non-Melanoma Skin Cancer.
Griffin LL; Lear JT
Cancers (Basel); 2016 Oct; 8(10):. PubMed ID: 27782094
[TBL] [Abstract][Full Text] [Related]
4. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
5. Daylight Photodynamic Therapy for Actinic Keratoses.
Morton CA; Braathen LR
Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
7. Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers.
Tarstedt M; Gillstedt M; Wennberg Larkö AM; Paoli J
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):420-3. PubMed ID: 26841041
[TBL] [Abstract][Full Text] [Related]
8. Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT.
Lee PK; Kloser A
J Drugs Dermatol; 2013 Aug; 12(8):925-30. PubMed ID: 23986167
[TBL] [Abstract][Full Text] [Related]
9. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma.
Morton CA; Szeimies RM; Sidoroff A; Braathen LR
J Eur Acad Dermatol Venereol; 2013 May; 27(5):536-44. PubMed ID: 23181594
[TBL] [Abstract][Full Text] [Related]
10. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours.
Calzavara-Pinton PG
J Photochem Photobiol B; 1995 Jul; 29(1):53-7. PubMed ID: 7472803
[TBL] [Abstract][Full Text] [Related]
11. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
[TBL] [Abstract][Full Text] [Related]
14. Taking treatment decisions in non-melanoma skin cancer--the place for topical photodynamic therapy (PDT).
Sidoroff A; Thaler P
Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):24-32. PubMed ID: 20230990
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma.
Caekelbergh K; Annemans L; Lambert J; Roelandts R
Br J Dermatol; 2006 Oct; 155(4):784-90. PubMed ID: 16965429
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?
Morton CA
J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy in the management of actinic keratosis: Retrospective evaluation of outcome.
Jerjes W; Hamdoon Z; Abdulkareem AA; Hopper C
Photodiagnosis Photodyn Ther; 2017 Mar; 17():200-204. PubMed ID: 27174210
[TBL] [Abstract][Full Text] [Related]
18. Aminolevulinic acid photodynamic therapy for skin cancers.
Blume JE; Oseroff AR
Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices.
Zeitouni NC; Bhatia N; Ceilley RI; Cohen JL; Del Rosso JQ; Moore AY; Munavalli G; Pariser DM; Schlesinger T; Siegel DM; Willey A; Goldman MP
J Clin Aesthet Dermatol; 2021 Oct; 14(10):E53-E65. PubMed ID: 34976292
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy (PDT) using topically applied δ-aminolevulinic acid (ALA) for the treatment of malignant skin tumors.
Sieroń A; Kawczyk-Krupka A; Cebula MA; Szyguła M; Zieleżnik W; Gruk M; Suwała-Jurczyk B
Photodiagnosis Photodyn Ther; 2004 Dec; 1(4):311-7. PubMed ID: 25048435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
